CUSIP: 75082Q105
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,158,636
-
Share change
-
-513,125
-
Total reported value
-
$13,923,249
-
Put/Call ratio
-
2.5%
-
Price per share
-
$0.86
-
Number of holders
-
56
-
Value change
-
-$859,902
-
Number of buys
-
23
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 75082Q105?
CUSIP 75082Q105 identifies RAIN - RAIN ONCOLOGY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP 75082Q105:
Institutional Holders of RAIN ONCOLOGY INC - COM (RAIN) as of Q3 2023
As of 30 Sep 2023,
RAIN ONCOLOGY INC - COM (RAIN) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,158,636 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BVF INC/IL, Samsara BioCapital, LLC, Boxer Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Acuitas Investments, LLC, Russell Investments Group, Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.